ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Immunovia Ab (publ)

Immunovia Ab (publ) (0G8X)

191,40
0,00
(0,00%)
Fermé 03 Décembre 5:30PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
191,40
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
191,40 Plage de 52 semaines 191,40
Cap du marché
Clôture Veille
191,40
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 602
Actions en circulation
45 287 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,02
Bénéfice par action (BPA)
-6,83
Chiffre d'affairess
1,65M
Bénéfice net
-309,44M

À propos de Immunovia Ab (publ)

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Siège social
Lund, Swe
Fondé
-
Immunovia Ab (publ) est coté dans le secteur Surgical,med Instr,apparatus de la London Stock Exchange avec le ticker 0G8X. Le dernier cours de clôture d'Immunovia Ab (publ) était de SEK191,40. Au cours de la dernière année, les actions de Immunovia Ab (publ) ont été négociées dans une fourchette de prix de SEK 191,40 à SEK 191,40.

Immunovia Ab (publ) compte actuellement 45 287 000 actions en circulation. La capitalisation boursière d'Immunovia Ab (publ) est de SEK8,67 milliard. Immunovia Ab (publ) a un ratio cours/bénéfice (ratio PE) de -0.02.

0G8X Dernières nouvelles

Immunovia announces financial calendar for financial year 2024

Immunovia announces financial calendar for financial year 2024 PR Newswire LUND, Sweden, Jan. 4, 2024 LUND, Sweden, Jan. 4, 2024 /PRNewswire/ -- Immunovia, a diagnostic company with the vision to...

Immunovia announces financial calendar for financial year 2024

Immunovia announces financial calendar for financial year 2024 PR Newswire LUND, Sweden, Jan. 4, 2024 LUND, Sweden, Jan. 4, 2024 /PRNewswire/ -- Immunovia, a diagnostic company with the vision to...

Bulletin from the extraordinary general meeting in Immunovia AB

Bulletin from the extraordinary general meeting in Immunovia AB PR Newswire LUND, Sweden, Nov. 21, 2023 LUND, Sweden, Nov. 21, 2023 /PRNewswire/ -- On 21st November 2023, an extraordinary general...

Bulletin from the extraordinary general meeting in Immunovia AB

Bulletin from the extraordinary general meeting in Immunovia AB PR Newswire LUND, Sweden, Nov. 21, 2023 LUND, Sweden, Nov. 21, 2023 /PRNewswire/ -- On 21st November 2023, an extraordinary general...

Immunovia Publishes Interim Report for January-September 2023

Immunovia Publishes Interim Report for January-September 2023 PR Newswire LUND, Sweden, Nov. 9, 2023 LUND, Sweden, Nov. 9, 2023 /PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488...

Immunovia Publishes Interim Report for January-September 2023

Immunovia Publishes Interim Report for January-September 2023 PR Newswire LUND, Sweden, Nov. 9, 2023 LUND, Sweden, Nov. 9, 2023 /PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488...

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully completes discovery phase of next-generation test development PR Newswire LUND, Sweden, Nov. 7, 2023 LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm:...

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully completes discovery phase of next-generation test development PR Newswire LUND, Sweden, Nov. 7, 2023 LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm:...

Invitation to Immunovia's Q3 presentation

Invitation to Immunovia's Q3 presentation PR Newswire LUND, Sweden, Nov. 2, 2023 LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Immunovia will publish its third quarter 2023 results on November 9...

Invitation to Immunovia's Q3 presentation

Invitation to Immunovia's Q3 presentation PR Newswire LUND, Sweden, Nov. 2, 2023 LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Immunovia will publish its third quarter 2023 results on November 9...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
100191.4191.4191.400DE
400191.4191.4191.4476191.4DE
1200191.4191.4191.41602191.4DE
2600191.4191.4191.41305191.4DE
5200191.4191.4191.42285191.4DE
15600191.4191.4191.41928191.4DE
26000191.4191.4191.41275191.4DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SCGLSealand Capital Galaxy Limited
0,54p
(80,00%)
36,26M
OBDOxford Biodynamics Plc
2,11p
(55,15%)
8,3M
MIRIMirriad Advertising Plc
0,18p
(33,33%)
23,04M
CLCOCloudcoco Group Plc
0,26p
(30,00%)
3,42M
IESInvinity Energy Systems Plc
15,00p
(27,66%)
4,57M
ZNTZentra Group Plc
3,50p
(-36,36%)
221,85k
UOGUnited Oil & Gas Plc
0,125p
(-34,21%)
123,45M
SYSSysgroup Plc
21,50p
(-24,56%)
788,98k
ADAAdams Plc
3,50p
(-22,22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3,70p
(-21,28%)
22,32k
ORCPOracle Power Plc
0,0525p
(-7,89%)
3,65B
NTVONativo Resources Plc
0,0023p
(-8,00%)
1,51B
SYMESupply@me Capital Plc
0,0031p
(-10,14%)
1,11B
KEFIKefi Gold And Copper Plc
0,524p
(-19,63%)
567,23M
ENETEthernity Networks Ltd
0,1425p
(18,75%)
551,92M
Aucune Discussion Trouvée
Ajouter une Discussion